[HMG-CoA reductase inhibitors].
Thiery
J
J
Institut für Klinische Chemie, Klinikum Grosshadern, München.
Seidel
D
D
D002986:Clinical Trials as Topic; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006950:Hyperlipidemia, Familial Combined / Q000097:blood / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids
HMG-CoA-Reduktasehemmer.